Brief: Tscan Therapeutics reports Q2 results

Tscan Therapeutics

10/08/2022 12:05

Aug 10 (Reuters) - TScan Therapeutics Inc  TCRX.O :
    * TSCAN THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
AND HIGHLIGHTS RECENT PROGRESS
    * TSCAN THERAPEUTICS INC - ENDED QUARTER WITH CASH AND CASH
EQUIVALENTS OF $125.6 MILLION, FUNDING OPERATIONS INTO 2024
    * TSCAN THERAPEUTICS - REVENUE FOR Q2 ENDED JUNE 30, 2022,
WAS
$4.1 MILLION, COMPARED TO $2.8 MILLION FOR Q2 ENDED JUNE 30,
2021
    * TSCAN THERAPEUTICS INC QTRLY NET LOSS PER SHARE, BASIC AND
DILUTED $0.63

Source text for Eikon:  ID:nGNX27GZNb 
Further company coverage:  TCRX.O